News FDA Clears Rapid Blood Test for Mild Traumatic Brain Injury By Brian Park, PharmD Publish Date January 12, 2021
News Use of Direct Acting Antivirals With Potent Inducers Examined in Case Series By Cassandra Pardini, PharmD Publish Date January 11, 2021
News Mirabegron Granted Priority Review for Neurogenic Detrusor Overactivity By Brian Park, PharmD Publish Date January 7, 2021
Features Jury Awards Huge Verdict After Physician Fails to Diagnose Rare Disorder By Ann W. Latner, JD Publish Date January 4, 2021
News Xeomin Approved for Pediatric Patients With Chronic Sialorrhea By Brian Park, PharmD Publish Date December 22, 2020
News New Guidelines for the Management of Lyme Disease By Amit Akirov, MD Publish Date December 17, 2020
News FDA Approves Shorter Infusion Time for MS Drug Ocrevus By Brian Park, PharmD Publish Date December 15, 2020
News Pet Meds Listed in Owner’s Medication Profile Lead to Confusion in the ED By Cassandra Pardini, PharmD Publish Date December 3, 2020
News Additional Administration Option Approved for Nuplazid Capsules By Brian Park, PharmD Publish Date December 3, 2020
News Anticholinergics Linked to Increased Dementia Risk By Natasha Persaud Publish Date December 1, 2020
Drugs in the Pipeline Trehalose Designated Orphan Drug for ALS By Brian Park, PharmD Publish Date November 23, 2020
News Vimpat Approved for Primary Generalized Tonic-Clonic Seizures By Diana Ernst, RPh Publish Date November 18, 2020
News FDA Panel Votes on Aducanumab for Alzheimer Disease By Diana Ernst, RPh Publish Date November 10, 2020
News Room Temperature Stable Fosphenytoin Gets FDA Approval By Brian Park, PharmD Publish Date November 10, 2020
News Nerivio Device Cleared for Use in Patients With Chronic Migraine By Brian Park, PharmD Publish Date October 27, 2020
Drugs in the Pipeline Idiopathic Hypersomnia Study Evaluating Xywav Meets End Points By Brian Park, PharmD Publish Date October 9, 2020